Mazor Rises to Highest Level in 3 Weeks on Regulatory Approval

Mazor Robotics Ltd. (MZOR) advanced to the highest level in three weeks after receiving regulatory approval to market its Renaissance spinal surgery guidance system in South Korea.

The shares advanced 5.4 percent in intraday trading to 4.211 shekels, the highest level since May 20, as of 10:50 a.m. in Tel Aviv.

To contact the reporter on this story: David Wainer in Tel Aviv at

To contact the editor responsible for this story: Claudia Maedler at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.